{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:08:49Z","timestamp":1789085329996,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016608","name":"Rainwater Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008539","name":"Curepsp","doi-asserted-by":"publisher","award":["669-2020-06"],"award-info":[{"award-number":["669-2020-06"]}],"id":[{"id":"10.13039\/100008539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jlr.2025.100952","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:45:10Z","timestamp":1764290710000},"page":"100952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of the brain lipidome associated with frontotemporal lobar degeneration MAPT P301S mutation"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1238-8471","authenticated-orcid":false,"given":"Almudena","family":"Maroto-Juanes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7372-8946","authenticated-orcid":false,"given":"Sascha","family":"Koppes-den Hertog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-8308","authenticated-orcid":false,"given":"Dieter","family":"L\u00fctjohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1684-1894","authenticated-orcid":false,"given":"Martin","family":"Giera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7023-0106","authenticated-orcid":false,"given":"Rik","family":"van der Kant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2025.100952_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","article-title":"Molecular pathogenesis of the tauopathies","volume":"14","author":"G\u00f6tz","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jlr.2025.100952_bib2","first-page":"229","article-title":"Mise en evidence immunologique de la proteine tau au nivea u des lesions de degenerescence neurofibrillaire de la maladie d\u2019Alzheimer","volume":"95","author":"Brion","year":"1985","journal-title":"Arch. Biol. (Bruxelles)"},{"key":"10.1016\/j.jlr.2025.100952_bib3","first-page":"4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein X (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Med. Sci."},{"key":"10.1016\/j.jlr.2025.100952_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jlr.2025.100952_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jlr.2025.100952_bib6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jlr.2025.100952_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00401-008-0460-5","article-title":"Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations","volume":"117","author":"Mackenzie","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jlr.2025.100952_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ana.20668","article-title":"Phenotypic heterogeneity within a new family with the MAPT P301S mutation","volume":"58","author":"Yasuda","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jlr.2025.100952_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jlr.2025.100952_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/brain\/awad388","article-title":"Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease","volume":"147","author":"Chu","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2025.100952_bib11","first-page":"693","article-title":"Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer\u2019s disease brain tissues","volume":"64","author":"Shin","year":"1991","journal-title":"Lab Invest."},{"key":"10.1016\/j.jlr.2025.100952_bib12","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1073\/pnas.92.22.10369","article-title":"Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes","volume":"92","author":"LoPresti","year":"1995","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2025.100952_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","article-title":"Neuropathology of frontotemporal lobar Degeneration-Tau (FTLD-Tau)","volume":"45","author":"Dickson","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ana.410410222","article-title":"Genetic evidence for the involvement of \u03c4 in progressive supranuclear palsy","volume":"41","author":"Conrad","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jlr.2025.100952_bib15","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease","volume":"41","author":"Sim\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2025.100952_bib16","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","article-title":"Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein","volume":"22","author":"Allen","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.jlr.2025.100952_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-024-02771-5","article-title":"Severe neurodegeneration in brains of transgenic rats producing human tau prions","volume":"148","author":"Ayers","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jlr.2025.100952_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K","article-title":"FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation","volume":"46","author":"Sperfeld","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jlr.2025.100952_bib20","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1523\/JNEUROSCI.4922-11.2012","article-title":"The microtubule-stabilizing agent, Epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged Tau transgenic mice","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","article-title":"Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy","volume":"33","author":"Iba","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021050","article-title":"P301S mutant human Tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating","volume":"6","author":"Takeuchi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2025.100952_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2021.09.006","article-title":"Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy","volume":"109","author":"Patel","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jlr.2025.100952_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-020-01749-w","article-title":"The behavioural and neuropathologic sexual dimorphism and absence of MIP-3\u03b1 in tau P301S mouse model of Alzheimer\u2019s disease","volume":"17","author":"Sun","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jlr.2025.100952_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41514-021-00064-9","article-title":"Abnormal brain cholesterol homeostasis in Alzheimer\u2019s disease\u2014a targeted metabolomic and transcriptomic study","volume":"7","author":"Varma","year":"2021","journal-title":"NPJ Aging Mech. Dis."},{"key":"10.1016\/j.jlr.2025.100952_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.690372","article-title":"Cholesterol and Alzheimer\u2019s disease; from risk genes to pathological effects","volume":"13","author":"Feringa","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2016.10.008","article-title":"Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson\u2019s disease","volume":"101","author":"Doria","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jlr.2025.100952_bib28","doi-asserted-by":"crossref","first-page":"27646","DOI":"10.1073\/pnas.2003021117","article-title":"Cell type-specific lipid storage changes in Parkinson\u2019s disease patient brains are recapitulated by experimental glycolipid disturbance","volume":"117","author":"Brekk","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2025.100952_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10719-021-10023-x","article-title":"Glycosphingolipid metabolism and its role in ageing and Parkinson\u2019s disease","volume":"39","author":"Wallom","year":"2022","journal-title":"Glycoconj J."},{"key":"10.1016\/j.jlr.2025.100952_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.797220","article-title":"Altered cholesterol homeostasis in Huntington\u2019s disease","volume":"14","author":"Kacher","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson\u2019s disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jlr.2025.100952_bib32","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment","volume":"73","author":"Fanning","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jlr.2025.100952_bib33","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.celrep.2018.11.028","article-title":"Inhibiting stearoyl-CoA desaturase ameliorates \u03b1-synuclein cytotoxicity","volume":"25","author":"Vincent","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2025.100952_bib34","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.stemcr.2022.07.011","article-title":"Human tau mutations in cerebral organoids induce a progressive dyshomeostasis of cholesterol","volume":"17","author":"Glasauer","year":"2022","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jlr.2025.100952_bib35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232000","article-title":"Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy","volume":"221","author":"Toral-Rios","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jlr.2025.100952_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106538","article-title":"Dysregulated expression of cholesterol biosynthetic genes in Alzheimer\u2019s disease alters epigenomic signatures of hippocampal neurons","volume":"198","author":"Paiva","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jlr.2025.100952_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104832","article-title":"Co-expression network analysis of human tau-transgenic mice reveals protein modules associated with tau-induced pathologies","volume":"25","author":"Tsumagari","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jlr.2025.100952_bib38","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1093\/hmg\/ddv268","article-title":"Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology","volume":"24","author":"Burlot","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2025.100952_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12974-024-03060-4","article-title":"Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies","volume":"21","author":"Ole\u0161ov\u00e1","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jlr.2025.100952_bib40","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41593-024-01740-1","article-title":"Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress","volume":"27","author":"Goodman","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100952_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib43","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuron.2023.10.023","article-title":"Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist","volume":"112","author":"Litvinchuk","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.jlr.2025.100952_bib44","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/brain\/awv166","article-title":"CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer\u2019s disease","volume":"138","author":"Djelti","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2025.100952_bib45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","article-title":"Cholesterol metabolism is a druggable axis that independently regulates Tau and amyloid-\u03b2 in iPSC-derived Alzheimer\u2019s disease neurons","volume":"24","author":"van der Kant","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jlr.2025.100952_bib46","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1021\/acsptsci.4c00229","article-title":"Challenges and opportunities for consideration of Efavirenz drug repurposing for Alzheimer\u2019s disease therapeutics","volume":"7","author":"Boyarko","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jlr.2025.100952_bib47","series-title":"A phase 2a, Dose-Finding, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Efavirenz in Patients with Early Alzheimer\u2019s Disease. EUCTR 2023-509613-37\u201301","year":"2023"},{"key":"10.1016\/j.jlr.2025.100952_bib48","first-page":"53257","article-title":"A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS","volume":"104","author":"Hatzipetros","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jlr.2025.100952_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nprot.2006.2","article-title":"T-maze alternation in the rodent","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jlr.2025.100952_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2019.03.009","article-title":"The isoflavones genistein and daidzein increase hepatic concentration of thyroid hormones and affect cholesterol metabolism in middle-aged male rats","volume":"190","author":"\u0160o\u0161i\u0107-Jurjevi\u0107","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jlr.2025.100952_bib51","doi-asserted-by":"crossref","first-page":"16369","DOI":"10.1021\/acs.analchem.1c02826","article-title":"Cross-laboratory standardization of preclinical lipidomics using differential mobility spectrometry and multiple reaction monitoring","volume":"93","author":"Ghorasaini","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jlr.2025.100952_bib52","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1021\/jasms.1c00203","article-title":"A DMS shotgun lipidomics workflow application to facilitate high-throughput, comprehensive lipidomics","volume":"32","author":"Su","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jlr.2025.100952_bib53","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/s42255-025-01365-z","article-title":"The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases","volume":"7","author":"Feringa","year":"2025","journal-title":"Nat. Met."},{"key":"10.1016\/j.jlr.2025.100952_bib54","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41598-024-51463-3","article-title":"Brain areas lipidomics in female transgenic mouse model of Alzheimer\u2019s disease","volume":"14","author":"Ferr\u00e9-Gonz\u00e1lez","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100952_bib55","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/febs.16638","article-title":"Upstream lipid and metabolic systems are potential causes of Alzheimer\u2019s disease, Parkinson\u2019s disease and dementias","volume":"291","author":"Cooper","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.jlr.2025.100952_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnana.2018.00083","article-title":"Cell densities in the mouse brain: a systematic review","volume":"12","author":"Keller","year":"2018","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.jlr.2025.100952_bib57","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1111\/febs.12559","article-title":"Glycosphingolipids: synthesis and functions","volume":"280","author":"D\u2019Angelo","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.jlr.2025.100952_bib58","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2025.100952_bib59","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of lipids in Alzheimer\u2019s disease pathology and potential therapies","volume":"11","author":"Chew","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jlr.2025.100952_bib60","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3390\/cells10102591","article-title":"Lipid profiling of Alzheimer\u2019s disease brain highlights enrichment in glycerol(phospho)lipid, and sphingolipid metabolism","volume":"10","author":"Akyol","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2025.100952_bib61","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s12276-023-01018-9","article-title":"Functional roles of sphingolipids in immunity and their implication in disease","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jlr.2025.100952_bib62","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fneur.2020.00437","article-title":"Exploring sphingolipid implications in neurodegeneration","volume":"11","author":"Alessenko","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jlr.2025.100952_bib63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1471-4159.2007.04822.x","article-title":"Lactosylceramide: a lipid second messenger in neuroinflammatory disease","volume":"103","author":"Won","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jlr.2025.100952_bib64","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206083119","article-title":"Metabolome-wide association study on ABCA7 indicates a role of ceramide metabolism in Alzheimer\u2019s disease","volume":"119","author":"Dehghan","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2025.100952_bib65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mitoco.2022.10.002","article-title":"The metabolism and function of phospholipids in Mitochondria","volume":"1","author":"Dong","year":"2023","journal-title":"Mitochondrial Commun."},{"key":"10.1016\/j.jlr.2025.100952_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1094273","article-title":"Phosphatidylethanolamine homeostasis under conditions of impaired CDP-ethanolamine pathway or phosphatidylserine decarboxylation","volume":"9","author":"St Germain","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jlr.2025.100952_bib67","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1074\/jbc.M112.434183","article-title":"Phosphatidylethanolamine deficiency in mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology","volume":"288","author":"Tasseva","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100952_bib68","doi-asserted-by":"crossref","first-page":"17577","DOI":"10.1016\/S0021-9258(18)45420-8","article-title":"Phosphorylation of tau proteins to a state like that in Alzheimer\u2019s brain is catalyzed by a calcium\/calmodulin-dependent kinase and modulated by phospholipids","volume":"262","author":"Baudier","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100952_bib69","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1038\/s41598-020-60457-w","article-title":"Uncovering pathophysiological changes in frontotemporal dementia using serum lipids","volume":"10","author":"Phan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100952_bib70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-cellbio-100616-060608","article-title":"Lipid droplet biogenesis","volume":"33","author":"Walther","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jlr.2025.100952_bib71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100952_bib72","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jlr.2025.100952_bib73","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cmet.2024.03.014","article-title":"Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100952_bib74","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","article-title":"Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses","volume":"101","author":"Blalock","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2025.100952_bib75","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2025.100952_bib76","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100952_bib77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/BC.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100952_bib78","doi-asserted-by":"crossref","first-page":"23712","DOI":"10.1074\/jbc.M114.556159","article-title":"Effects of a disrupted blood-brain barrier on cholesterol homeostasis in the brain","volume":"289","author":"Saeed","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100952_bib79","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","article-title":"Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases","volume":"33","author":"Song","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100952_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70077","article-title":"Fibrillar tau alters cerebral endothelial cell metabolism, vascular inflammatory activation, and barrier function in vitro and in vivo","volume":"21","author":"Guzm\u00e1n-Hern\u00e1ndez","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jlr.2025.100952_bib81","article-title":"Circulatory proteins shape microglia state and boost phagocytosis","author":"Lu","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jlr.2025.100952_bib82","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1194\/jlr.M017244","article-title":"Dietary intake of plant sterols stably increases plant sterol levels in the murine brain","volume":"53","author":"Vanmierlo","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100952_bib83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11130-011-0219-3","article-title":"Cerebral accumulation of dietary derivable plant sterols does not interfere with memory and anxiety related behavior in Abcg5\u2212\/\u2212 mice","volume":"66","author":"Vanmierlo","year":"2011","journal-title":"Plant Foods Hum. Nutr."},{"key":"10.1016\/j.jlr.2025.100952_bib84","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2015.01.003","article-title":"Organization and evolution of brain lipidome revealed by large-scale analysis of human, chimpanzee, macaque, and mouse tissues","volume":"85","author":"Bozek","year":"2015","journal-title":"Neuron"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525002159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525002159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:30:18Z","timestamp":1789083018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227525002159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0022227525002159"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100952","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the brain lipidome associated with frontotemporal lobar degeneration MAPT P301S mutation","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100952"}}